학술논문
Brigatinib (BRG) in Asian vs non-Asian patients (pts) with crizotinib (CRZ)-refractory ALK plus NSCLC in the phase II ALTA trial
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15698041